Clinical trial
Can Blood Flow Restriction Training Counteract Sarcopenia After TIPS in People With Liver Cirrhosis?
NCT07936552 is registered in ClinicalTrials.gov with German Diabetes Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can Blood Flow Restriction Training Counteract Sarcopenia After TIPS in People With Liver Cirrhosis?
- Lead sponsor
- German Diabetes Center
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 2, 2027
- Completion date
- December 31, 2029
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver cirrhosis, tips insertion
Arms
As registered; 2 arms.
-
Blood-flow restriction training (BFRT)
Resistance training with low loads (30% 1-RM) in combination with a brief occlusion of venous blood flow using a tourniquet while exercising.
-
Control group
The control group will receive standard care following TIPS placement, including routine clinical follow-up but without training.
Primary endpoints
Registered primary outcome measures; 2 primary.
-
Change in skeletal muscle function by blood flow restriction training
Assessed by the phosphocreatine (PCr) recovery half-time by phosphorus-31 magnetic resonance spectroscopy (³¹P-MRS) . The PCr recovery serves is an indicator of the skeletal muscle oxidative capacity, with shorter recovery times reflecting better muscle function.
-
Change in skeletal muscle mass by blood flow restriction training
Assessed by the skeletal muscle volume (cm\^3) of the thigh and lower leg by magnetic resonance imaging (MRI).
Lead sponsor's other trials
German Diabetes Center, most recent start first.
+25 more trials
Similar trials
Same condition (Liver Cirrhosis) and phase, most recent start first.
+352 more trials See the condition page